ANTIBODY DRUG CONJUGATES MARKET: MARKET SIZE, TARGET AUDIENCE, COMPETITIVE OVERVIEW, AND 2034 PROJECTIONS

Antibody-drug conjugates (ADCs) are a groundbreaking innovation in cancer therapy, combining monoclonal antibodies with potent cytotoxic drugs to enable targeted treatment. This advanced approach enhances therapeutic efficacy while minimizing systemic toxicity, making ADCs a crucial advancement in oncology. As cancer rat